Please register for the Squamous cell NSCLC webinar 11/12

[CindyA]

Podcasts, Videos and Webinars

Squamous Cell NSCLC: Growing Understanding and Expanding Treatment Options

Join us for a webinar on November 12

Space is limited. Click to reserve your webinar seat now.

GRACE and LUNGevity are very pleased to offer another webinar, on Tuesday, November 12, at 2-3 pm Eastern, 11 am - noon Pacific, on a topic that has been building momentum based on an emerging focus as a subject of clinical research.

We're happy to welcome back Dr. David Spigel, lung cancer expert at the Sarah Cannon Cancer Center in Nashville, TN, and Director of the Clinical Research Program to discuss current and evolving management issues in squamous cell carcinoma.

Squamous cell carcinoma represents 20% to 25% of non-small cell lung cancer (NSCLC) in North America and approximately a third of cases in Europe, but over the last decade more of the developments in NSCLC have focused on patients with an adenocarcinoma or the broader range of "non-squamous" NSCLC. However, over the last few years, we have seen some new treatment options that include or even focus on patients with squamous NSCLC, ranging from standard chemotherapy to new potential targets to immunotherapy platforms that may be especially active in patients with squamous NSCLC.

Dr. Spigel will review some basic issues in the biology of squamous cell carcinoma, how it differs in clinical behavior from adenocarcinoma, and how new research avenues are focusing on this large but historically understudied group of lung cancer patients. Though we'll make the content of the program available as a series of podcasts after the program, we encourage you to sign up for the live event, where you'll have the chance to ask questions and follow Dr. Spigel's dynamic presentation in real time. As always, registration is free, so sign up today!

After registering you will receive a confirmation email containing information about joining the webinar.